Yi-Ming Chen Selected Research

Rheumatoid Arthritis

1/2024	Association of atypical anti-neutrophil cytoplasmic antibody with comorbidities and outcome in a hospital-based population.
1/2024	Exosomal microRNAs as biomarkers for viral replication in tofacitinib-treated rheumatoid arthritis patients with hepatitis C.
9/2023	The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study.
9/2023	Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis.
8/2023	Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis.
12/2022	The Impact of b/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis.
1/2021	Folinate Supplementation Ameliorates Methotrexate Induced Mitochondrial Formate Depletion In Vitro and In Vivo.
12/2020	Association of Apolipoprotein E Polymorphism with Adipokines and Cardiovascular Disease Risk in Rheumatoid Arthritis Patients.
10/2020	Herpes Zoster in rheumatoid arthritis patients receiving tofacitinib, a single center experience from Taiwan.
1/2020	Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Ming Chen Research Topics

Disease

47	Rheumatoid Arthritis 01/2024 - 01/2009
19	Infections 01/2024 - 01/2007
14	Inflammation (Inflammations) 04/2024 - 02/2011
13	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 12/2010
13	Fatigue 01/2024 - 03/2014
11	Neoplasms (Cancer) 01/2024 - 12/2010
11	Adult-Onset Still's Disease 02/2022 - 10/2009
9	Diabetes Mellitus 01/2024 - 12/2009
8	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 10/2013
8	Tuberculosis (Tuberculoses) 03/2024 - 02/2012
8	Necrosis 09/2023 - 02/2011
8	Arthritis (Polyarthritis) 05/2022 - 10/2009
7	Ankylosing Spondylitis 10/2023 - 11/2015
6	Hyperlipidemias (Hyperlipidemia) 12/2021 - 11/2011
5	Rheumatic Diseases (Rheumatism) 12/2023 - 01/2020
5	Stroke (Strokes) 01/2022 - 12/2009
5	Hepatitis 01/2022 - 10/2018
4	Lupus Nephritis 04/2024 - 09/2016
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 11/2016
4	Myocardial Infarction 09/2023 - 01/2021
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2017
4	Hypertension (High Blood Pressure) 01/2021 - 09/2013
4	Hepatitis B 06/2019 - 10/2011
4	Acquired Immunodeficiency Syndrome (AIDS) 02/2018 - 07/2006
3	Hypersensitivity (Allergy) 05/2024 - 09/2015
3	Hepatitis C 01/2024 - 01/2018
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2024 - 10/2023
3	Osteoporosis 01/2022 - 11/2011
3	Nephritis 01/2022 - 09/2016
3	Cognitive Dysfunction 01/2022 - 11/2010
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2016
3	Atherosclerosis 12/2020 - 03/2015
3	Insulin Resistance 12/2020 - 03/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 04/2008
3	Periodontitis 01/2020 - 07/2013
3	Experimental Arthritis 12/2017 - 12/2015
3	Hepatocellular Carcinoma (Hepatoma) 02/2014 - 05/2011

Drug/Important Bio-Agent (IBA)

16	CytokinesIBA 01/2023 - 01/2009
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2009
13	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2012
9	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 01/2016
9	AntibodiesIBA 01/2024 - 09/2009
9	AmmoniaIBA 04/2020 - 03/2014
9	Lactic Acid (Lactate)FDA LinkGeneric 04/2020 - 03/2014
8	Interleukin-17 (Interleukin 17)IBA 04/2024 - 07/2011
8	Antirheumatic Agents (DMARD)IBA 08/2023 - 01/2016
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2022 - 07/2011
8	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2009
7	Creatine Kinase (Creatine Phosphokinase)IBA 04/2020 - 03/2014
7	Adalimumab (Humira)FDA Link 01/2020 - 03/2015
6	Etanercept (Enbrel)FDA Link 01/2016 - 12/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2010
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2023 - 07/2015
5	CholesterolIBA 11/2022 - 12/2009
5	Immunoglobulin G (IgG)IBA 01/2022 - 08/2010
5	oxidized low density lipoproteinIBA 01/2021 - 05/2015
5	Urea (Carbamide)FDA LinkGeneric 04/2020 - 01/2016
5	NitrogenIBA 04/2020 - 01/2016
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2011
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2014
4	CreatinineIBA 04/2024 - 01/2020
4	SteroidsIBA 03/2024 - 01/2018
4	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2018
4	tofacitinibIBA 01/2024 - 01/2018
4	Complement System Proteins (Complement)IBA 01/2024 - 09/2016
4	GlucocorticoidsIBA 01/2024 - 07/2015
4	tocilizumab (atlizumab)FDA Link 02/2022 - 01/2017
4	EnzymesIBA 10/2021 - 08/2014
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2009
4	Phosphotransferases (Kinase)IBA 10/2019 - 10/2011
4	Rituximab (Mabthera)FDA Link 06/2019 - 04/2013
4	GlycogenIBA 05/2019 - 01/2016
4	Isoniazid (Ftivazide)FDA LinkGeneric 02/2019 - 02/2012
4	ORALIT (ORS)IBA 01/2019 - 07/2013
4	AntigensIBA 01/2018 - 12/2010
3	VaccinesIBA 05/2024 - 01/2022
3	Antiviral Agents (Antivirals)IBA 01/2024 - 02/2019
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2023 - 01/2020
3	Cytochrome P-450 CYP2C19IBA 11/2023 - 01/2022
3	Clopidogrel (Plavix)FDA Link 09/2023 - 01/2022
3	AutoantibodiesIBA 07/2023 - 11/2021
3	Uric Acid (Urate)IBA 01/2023 - 01/2021
3	CalciumIBA 12/2022 - 12/2021
3	InterferonsIBA 01/2022 - 02/2012
3	ImmunosorbentsIBA 10/2021 - 08/2014
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2021 - 10/2011
3	LipidsIBA 01/2021 - 12/2009
3	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 09/2009
3	LDL CholesterolIBA 01/2021 - 05/2015
3	Blood Glucose (Blood Sugar)IBA 04/2020 - 07/2018
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 05/2011
3	Hemoglobins (Hemoglobin)IBA 12/2016 - 11/2010
3	lardIBA 03/2016 - 05/2015
3	GoldIBA 01/2016 - 02/2012
3	Rheumatoid FactorIBA 03/2015 - 09/2009
3	C-Reactive ProteinIBA 09/2014 - 01/2011
3	Immunoglobulin M (IgM)IBA 01/2014 - 08/2010
2	Carbon MonoxideIBA 01/2024 - 11/2021

Therapy/Procedure

23	Therapeutics 01/2024 - 07/2010
8	Biological Therapy 01/2023 - 03/2015